More recently, Schlingmann et al. highlighted the role of CYP24A1 mutations in predisposing to pregnancy- and lactation-associated hypercalcemia, underscoring the importance of genetic evaluation in such patients [6]. The gene discussed is CYP24A1; the disease is Hypercalcemia.